Abstract

Acute liver failure (ALF) is a rare but frequently devastating condition, with the potential to disable virtually every organ and system in the body. However, if it is recognised swiftly, and if its specific complications are managed actively, a good outcome can be achieved, especially in the young. The first hours are crucial in stabilising the patient, optimising metabolic and cardiovascular parameters, and reducing the risk of permanent neurological injury or brain death. Simultaneous liason with a specialist unit will allow a planned, safe transfer and access to definitive treatment such as liver transplantation, should the patient require it.

This review highlights the clinical and laboratory features of ALF, emphasises aspects of early treatment which will aid short term survival, and makes recommendations concerning safe transfer to a liver unit. Information is also given to aid early counselling of relatives and next of kin.
[download-attachments container="div" style="list" dipslay_icon="1" display_count="1" display__size="0"]

References

1. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in Liver Diseases. New York: Grune & Stratton, 1970: 282-298
2. O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993; 342: 273-5
3. Bernal W. Changing patterns of causation and the use of transplantation in the United kingdom. Semin Liver Dis. 2003 Aug; 23(3): 227-37.
4. Stedman C. Herbal hepatotoxicity. Semin Liver Disease 2002; 22: 195-206
5. Wijkicks EFM, Nyberg SL. Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc 2002; 34: 1220-1222
6. Jalan R, Olde Daminsk SWM, Deutz NEP, et al. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology 2004; 127: 1338-1346
7. Murphy N, Auzinger G, Bernal W, Wendon J. The effect of hypertonic sodium chloride on intracranial hypertension in patients with acute liver failure. Hepatology 2002; 39: 464-470
8. Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in criticially ill patients with acute hepatic and renal failure. Crit Care Med 1993; 21: 328- 338
9. Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infection in acute liver failure. Semin Liver Dis. 1996; 16(4): 389-402
10. Harrison PM, Keays R, Bray GP, et al. Improved outcome of paracetamolinduced fulminant hepatic failure by late administration of acetylcysteine. Lancet. 1990; 30: 1572–1573
11. Harry R, Auzinger G, Wendon J. The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology. 2002; 36: 395–402
12. Kodakar SK, Gopal PB, Wendon JA. Hyperglycemia is associated with intracranial hypertension in patients with acute liver failure. Liver Transpl. 2001; 7: C21
13. O’Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45
14. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet. 2002 Feb 16; 359(9306): 558-63.
15. O’Grady JG. Acute liver failure. In: O’Grady J, Lake J, Howdle P, eds. Comprehensive clinical hepatology. 1st ed. London: Mosby, 2000: 30.1-20